Nachrichten zur Pfizer Inc. Aktie

Pfizer Aktie: Immenser Schuldenberg

Kulmbach (www.aktiencheck.de) - Pfizer-Aktienanalyse von "Der Aktionär": Michel Doepke vom Anlegermagazin "Der Aktionär" nimmt in einer aktuellen Aktienanalyse die Aktie von…

Pfizer: 345. Dividende in Folge!

Der US-amerikanische Pharma-Riese Pfizer will auch im kommenden Kalenderjahr wieder hohe Dividenden an die Anteilseigner ausschütten. Wie aus einer Meldung…

Pfizer: 345. Dividende in Folge!

Der US-amerikanische Pharma-Riese Pfizer will auch im kommenden Kalenderjahr wieder hohe Dividenden an die Anteilseigner ausschütten. Wie aus einer Meldung…

Pfizer raises dividend by 2.4% to $0.43 a share

…

JPMorgan belässt Pfizer auf Neutral - Ziel 30 Dollar

NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Pfizer vor Prognosen für 2025 auf "Neutral" mit…

Pfizer: Peer-Leading Dividend And Potential Substantial Shareholder Returns

…

Health care execs seek to better understand patient outrage after UnitedHealthcare killing

Health care companies are taking a step back to better understand patients experiences after a powerful U.S. health insurance executive…

Pfizer Aktie: Guggenheim senkt Kursziel auf 33 USD - EPS-Prognosen angepasst

New York (www.aktiencheck.de) - Pfizer-Aktienanalyse von Guggenheim Securities: Rating und Kursziel Guggenheim hat das Kursziel für Pfizer Inc. (ISIN: US7170811035, WKN:…

2 Healthcare Stocks to Buy Hand Over Fist and 1 to Avoid

Ive long viewed healthcare as one of the best sectors for long-term investors because everybody requires healthcare products and services…

Pfizer Stock: A Golden Buying Opportunity (Rating Upgrade)

…

Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium

– Vepdegestrant in combination with abemaciclib demonstrated encouraging clinical activity (clinical benefit rate: 62.5%; overall response rate: 26.7%) in patients…

3 Magnificent S&P 500 Dividend Stock Down 35% to Buy and Hold Forever

The S&P 500 is at an all-time high. However, not all stocks in the widely followed index are setting records.…

2 No-Brainer Stocks to Buy Before the End of 2024

I think the stock markets valuation has become frothy. And Im in good company; Warren Buffetts actions show that he…

Should You Buy the S&P 500s Highest-Yielding Dividend Stocks Heading Into 2025?

Ill never get tired of praising dividend stocks as the markets unsung heroes. While they arent as sexy as high-flying…

Want an Extra $1,000 of Dividend Income in 2025? Invest $11,400 in These 3 High-Yield Stocks.

If youre trying to secure a stream of passive income to support your retirement dreams, theres more than one way…

Zacks.com featured highlights Urban Outfitters, Maplebear, Pfizer and Alcoa

Urban Outfitters, Maplebear, Pfizer and Alcoa have been highlighted in this Screen of The Week article.…

Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports By Reuters

Trump, RFK Jr. met with Pfizer, Lilly executives, Axios reports…

Pfizer: Too Cheap To Ignore

…

Should You Forget Pfizer and Buy These Unstoppable Stocks Instead?

Things arent getting much better for Pfizer (NYSE: PFE). The company is still suffering from the significant drop in sales…

Got $5,000? These 3 Growth Stocks Are Bargain Buys Right Now.

Investing $5,000 can be a good amount to put into a growth stock because it can lead to significant long-term…

Pfizer Stock Falls 8% in a Month: Should You Buy the Dip?

Investors with a long-term horizon may consider buying PFE stock at its present attractive valuation.…

Looking for Earnings Beat? Buy These 4 Top-Ranked Stocks

Top-ranked stocks Urban Outfitters, Maplebear, Pfizer and Alcoa are likely to beat on the bottom line in their upcoming releases.…

Are Pfizer Inc.s (NYSE:PFE) Mixed Financials The Reason For Its Gloomy Performance on The Stock Market?

It is hard to get excited after looking at Pfizers (NYSE:PFE) recent performance, when its stock has declined 10.0...…

Pfizers New Chief Scientific Officer Charts R&D Vision For High And Low-Risk Investments

…

After Crashing 27% in the Past Month, Is Viking Therapeutics Stock a Bargain Buy Right Now?

Theres a growing number of companies entering the weight loss space, focusing on GLP-1 drugs which can be game changers…

3 Magnificent Dividend Stocks With Yields Above 6% to Buy in December

The past couple of years have been terrific for stocks, with the benchmark S&P 500 index up a whopping 57.1%…

Mastercard, Broadcom, Pfizer Among Two Dozen Companies To Announce Dividend Increases In December

…

3 Fantastic Dividend Stocks to Buy Sooner Rather Than Later

You dont have to be an income investor to like dividends. Many billionaires who definitely dont need income still have…

Is This a New Reason to Buy Pfizer Stock Hand Over Fist?

Despite Pfizers (NYSE: PFE) recent struggles with falling earnings and a bid by an activist investor to unseat its leadership,…

Pfizer Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 27 auf 29 US-Dollar angehoben, aber die…

Berenberg hebt Ziel für Pfizer auf 29 Dollar - Hold

HAMBURG (dpa-AFX Analyser) - Die Privatbank Berenberg hat das Kursziel für Pfizer von 27 auf 29 US-Dollar angehoben, aber die…

I Really Want to Invest in Palantir Technologies. Heres Why I Wont.

Every so often in an investors life, there will be a stock that you really want to own, but that…

Black Friday Sale for Income Investors: These 3 Ultra-High-Yield Dividend Stocks Are Bargain Buys

Its Black Friday, the biggest shopping day of the year. Shoppers across the country are elbowing their way through the…

Is Pfizer Stock in Trouble?

…

Is Pfizer Stock in Trouble?

One stock that just cant seem to catch a break of late is Pfizer (NYSE: PFE). Even though it posted…

Billionaires Are Buying Up Beaten-Down Pfizer Stock. Should You Follow Their Lead?

Nobody can predict the future, but its not hard to imagine increasing pharmaceutical sales. In 2022, prescription drug spending in…

Should You Buy the 3 Highest-Paying Dividend Stocks in the S&P 500?

The power of owning dividend-paying stocks is often underappreciated. Consider, for example, that a study by Hartford Funds and Ned…

2 High-Yield Dividend Stocks to Buy Now for a Lifetime of Passive Income

Investors looking for a way to pump up their passive income streams want to turn their attention toward the pharmaceutical…

Arvinas Announces Upcoming Vepdegestrant Poster Presentations at the 2024 San Antonio Breast Cancer Symposium

NEW HAVEN, Conn., Nov. 25, 2024 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN) today announced that three posters…

Down 47% Since March, Is CRISPR Therapeutics Stock a Buy on the Dip?

On Nov. 21, shares of CRISPR Therapeutics (NASDAQ: CRSP) were down 47% from a peak they reached in March. This…

Pfizer Aktie: Neutraler Standpunkt notwendig

Die Pfizer-Aktie verzeichnete am 23. November einen minimalen Kursanstieg von 0,04 Prozent auf 24,58 Euro im Vergleich zum Vortag. Diese…

Pfizer meets amyloidosis rival as BridgeBio wins FDA nod for Attruby

…

Pfizer Inc. (PFE) Jefferies London Healthcare Conference (Transcript)

…

Pfizer: High Dividend And Low Price Might Still Offset The Expanding Risks

…

2 Beaten-Down Healthcare Stocks to Buy Hand Over Fist

Every company faces challenges. Sometimes, those issues are deeply damaging to a corporations investment thesis. Other times, though, thats not…

2 Dividend Stocks That Pay More Than 6% That Retirees Can Safely Buy and Hold for Years

Collecting an above-average dividend payment can sometimes come with risks. High-yielding stocks can be due for cuts to their payouts…

150% in 12 Monaten: Diese Pharma-Aktie stellt Novo Nordisk, Pfizer und Co in den Schatten

Große Pharma-Unternehmen stehen in der Regel für einen defensiven Investmentcharakter. Mit einem relativ unbekannten europäischen Player, der inzwischen gut 30…

150% in 12 Monaten: Diese Pharma-Aktie stellt Novo Nordisk, Pfizer und Co in den Schatten

Große Pharma-Unternehmen stehen in der Regel für einen defensiven Investmentcharakter. Mit einem relativ unbekannten europäischen Player, der inzwischen gut 30…

Pfizer names insider Chris Boshoff as R&D chief

Pfizer said it has named Chris Boshoff, who led the drugmakers cancer research and marketing for more than a year,…

Pfizer names insider Chris Boshoff as R&D chief By Reuters

Pfizer names insider Chris Boshoff as R&D chief…